INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,062 Cr | ₹808 Cr | ₹645 Cr | ₹481 Cr | ₹518 Cr |
What is the latest Total Current Liabilities ratio of INDOCO REMEDIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹1,062 Cr |
| Mar2025 | ₹808 Cr |
| Mar2024 | ₹645 Cr |
| Mar2023 | ₹481 Cr |
| Mar2022 | ₹518 Cr |
How is Total Current Liabilities of INDOCO REMEDIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,062 Cr | 31.34 | |
| Mar2025 | ₹808 Cr | 25.25 | |
| Mar2024 | ₹645 Cr | 34.26 | |
| Mar2023 | ₹481 Cr | -7.21 | |
| Mar2022 | ₹518 Cr | - | |
Compare Total Current Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,179.2 Cr | 4.2% | -7.2% | -17% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 4.2% |
-7.2% |
-17% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses